Challenges and Opportunities Associated with Incorporating New Evidence of Drug-Mediated Cardioprotection in the Economic Modeling of Type 2 Diabetes: A Literature Review.

Willis, Michael; Asseburg, Christian; Nilsson, Andreas; Neslusan, Cheryl

Willis, Michael; Asseburg, Christian; Nilsson, Andreas; Neslusan, Cheryl.

Afiliação

Willis M; The Swedish Institute for Health Economics, Lund, Sweden. michael.willis@ihe.se.
Asseburg C; The Swedish Institute for Health Economics, Lund, Sweden.
Nilsson A; The Swedish Institute for Health Economics, Lund, Sweden.
Neslusan C; Janssen Global Services, LLC, Raritan, NJ, USA.

Diabetes Ther ; 10(5): 1753-1769, 2019 Oct.

Article em En | MEDLINE | ID: mdl-31446570

Palavras-chave

Cardioprotection; Cardiovascular outcomes; Modeling; Type 2 diabetes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Prognostic_studies / Systematic_reviews Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google